Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients
Conditions:   Shingles;   Zoster Intervention:   Biological: recombinant zoster vaccine Sponsor:   Prof Patrice Lalive Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2022 Category: Research Source Type: clinical trials